© Reuters. FILE PHOTO: An indication stands outdoors a Abbvie facility in Cambridge, Massachusetts, U.S., Could 20, 2021. REUTERS/Brian Snyder/File Photograph
(Reuters) – AbbVie Inc (NYSE:) mentioned on Wednesday the U.S. Meals and Drug Administration had declined to approve its Parkinson’s illness remedy for adults.
The U.S. well being regulator has sought further details about the supply pump, which is a part of the advertising utility, the drugmaker mentioned, and doesn’t need further efficacy and security trials.
Abbvie mentioned it plans to resubmit the advertising utility as quickly as potential.
Parkinson’s illness is a neurological illness that causes unintended or uncontrollable actions, comparable to shaking, stiffness, and problem with stability and coordination.
